Simplex Trading’s Nuvation Bio NUVB Stock Holding History

Simplex Trading’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$248K	Buy	43,700 +20,100	+85%	+$98.2K	﹤0.01%	4447
2026 Q1	$101K	Sell	23,600 -210,000	-90%	-$1.17M	﹤0.01%	5070
2025 Q4	$2.09M	Sell	233,600 -73,100	-24%	-$453K	﹤0.01%	1939
2025 Q3	$1.13M	Buy	+306,700	New	+$836K	﹤0.01%	2933
2025 Q2	–	Sell	-2,000	Closed	-$3K	–	9408
2025 Q1	$3K	Sell	2,000 -133,200	-99%	-$303K	﹤0.01%	7847
2024 Q4	$359K	Sell	135,200 -2,100	-2%	-$5.41K	﹤0.01%	3878
2024 Q3	$314K	Buy	137,300 +136,800	+27,360%	+$417K	﹤0.01%	4075
2024 Q2	$1K	Buy	+500	New	+$1.53K	﹤0.01%	8510
2021 Q4	–	Sell	-3,800	Closed	-$35K	–	11117
2021 Q3	$35K	Hold	3,800	–	–	﹤0.01%	7955
2021 Q2	$35K	Buy	+3,800	New	+$43.3K	﹤0.01%	8086

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Simplex Trading's NUVB Position: Q2 2026 in Review

Simplex Trading reduced its Nuvation Bio (NUVB) stake by 88% in Q2 2026, selling an estimated $148K and leaving 4,066 shares worth $23.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6979.

Simplex Trading first reported a position in NUVB in Q2 2021 and has held it in 12 quarters since. The position peaked at $427K in Q3 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

Simplex Trading held 4,066 shares of Nuvation Bio worth $23.1K as of Q2 2026.
Simplex Trading sold 30,272 Nuvation Bio shares in Q2 2026, an estimated $148K.
Nuvation Bio made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6979 holding.
Simplex Trading first reported a position in Nuvation Bio in Q2 2021 and has held it in 12 quarters since.
Simplex Trading's Nuvation Bio position peaked at $427K in Q3 2025.
244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.